NCT00883844View on ClinicalTrials.gov

PEG-IFN in HBV Patients With Incomplete Response to NA

PHASE4CompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

April 30, 2009

Primary Completion Date

June 30, 2012

Study Completion Date

August 31, 2012

Conditions
Chronic Hepatitis B
Interventions
DRUG

Nucleos(t)ide analogue treatment with a peginterferon add-on strategy

peginterferon 1.5 microgram/kg once a week Treatment with one of the approved nucleos(t)ide analogues

DRUG

Nucleos(t)ide analogue treatment

Treatment with one of the approved nucleos(t)ide analogues

Trial Locations (2)

Unknown

AMC, Amsterdam

Erasmus MC, University Medical Center Rotterdam, Rotterdam

Sponsors
All Listed Sponsors
lead

Foundation for Liver Research

OTHER